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Zyxin is a focal adhesion protein that has been implicated in the modulation
of cell adhesion and motility, and is hypothesized to be a mechano-sensor in
integrin-mediated responses to mechanical force. To test the functional role of zyxin in the
mechanotransduction of microvascular smooth muscle cells (VSMC), we utilized atomic
force microscopy (AFM) to apply localized pulling forces to VSMC through a fibronectin
(FN) focal adhesion induced by a FN-coated bead on cell surface. Application of force
with the AFM induced an increase of zyxin accumulation at the site of the FN-bead focal
adhesion that accompanied the VSMC contractile response. Whereas, reduction of zyxin
expression by using a zyxin-shRNA construct abolished the VSMC contractile response
to AFM pulling forces, even though the zyxin-silenced VSMCs displayed increased
adhesion to FN in both AFM adhesion assays and cell adhesion assays. The reduced
zyxin expression significantly impaired cell spreading and reorganization of the actin
cytoskeleton that could indicate a possible underlying reason for the loss of a contractile
response to mechanical force. Consistent with these observations, in zyxin-silenced
VSMC, we also observed a reduced expression of Rac1, which plays an important role
in the actin reorganization in VSMC, but increased thyroid receptor-interacting proteins
(TRIP6) and FAK expression, the latter being a major protein that promote cell adhesion.
In conclusion, these data support an important enabling role for zyxin in VSMCs ability to
mechanically respond to applied force.
Keywords: shRNA silencing, integrin, mechanical forces, fibronectin, atomic force microscopy (AFM),
microcirculation, focal adhesion, extracellular matrix proteins
INTRODUCTION
Cell and extracellular matrix (ECM) interactions play crucial
roles in multiple cellular functions, such as cell adhesion, spread-
ing, motility, and shape (Schwartz, 1997; Zamir and Geiger,
2001). These processes are mediated by formation of protein
complexes at cell-ECM adhesion sites that begin as focal con-
tact points and mature into focal adhesions. Focal adhesions are
discrete, specialized regions at which cultured cells adhere to the
ECM, which are considered to be similar in structure and com-
position to microvascular smooth muscle cells (VSMC) adhesion
points in the vessel wall known as dense plaques. These struc-
tures serve as mechanical and biochemical signaling sites at which
integrin receptors cluster and bind to numerous signaling and
structural proteins to establish a connection between the ECM
and the actin cytoskeleton to mediate outside–in and inside–out
signaling events (Jockusch et al., 1995; Craig and Johnson, 1996).
Zyxin is one focal adhesion protein with a molecular weight
of 82KDa that was first isolated from chicken embryo fibroblasts
(Beckerle, 1986). Zyxin is a member of LIM domain protein fam-
ily that includes lipoma-preferred partner (LPP) (Gorenne et al.,
2003) and thyroid receptor-interacting proteins (TRIP6) (Yi and
Beckerle, 1998), all of which have been detected at focal adhesions
and cell-ECM and cell–cell junctional areas. LIM domain proteins
possess two distinct motifs: a proline-rich N-terminal region also
containing a nuclear export signaling sequences and a C-terminal
region consisting of three LIM domains (termed by the initials
of Lin-11, Isl-1, and Mec-3). Through the LIM domain- and the
N-terminal proline-rich domain-mediated protein–protein inter-
actions, zyxin forms complexes with molecules such as α-actinin
andMena/VASP, which are critically involved in actin polymeriza-
tion at focal adhesions as well as in stress fibers (Crawford et al.,
1992; Hoffman et al., 2006).
Recently, several lines of evidence have led to the postula-
tion that zyxin may function as a mechano-sensor. First, the
observation that zyxin can shuttle between a focal adhesion site
and cell nucleus (Nix and Beckerle, 1997) has raised specula-
tion that zyxin may be one of the long sought after mechano-
sensors that regulate gene transcription when prompted by
mechanical stimuli. Secondly, zyxin has displayed force sensi-
tive translocation to focal adhesions and stress fibers in fibrob-
lasts and endothelial cells (Yoshigi et al., 2005; Hirata et al.,
2008a,b; Ngu et al., 2010). Thirdly, it has been reported that
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when traction force at focal adhesions is reduced there is an
increase in the molecular unbinding kinetics (koff) of zyxin
(Lele et al., 2006). We have previously shown that arterio-
lar VSMC exhibits a contractile response when a stretching
force is applied perpendicular to the cell membrane through
fibronectin (FN)-induced focal adhesion sites on the cell sur-
face (Sun et al., 2008). This supports the existence of an inte-
grin mediated mechanotransduction pathway that can lead to
VSMC contraction. In this report, we tested the hypothesis that
zyxin was important for this integrin-mediated mechanotrans-
duction pathway by knockdown of zyxin expression using a
siRNA approach as well as atomic force microscopy (AFM) to
measure and apply forces to single focal adhesion sites on VSMC.
Our results showed that zyxin modulates the VSMC mechan-
otransduction by influencing cytoskeletal structure and signaling
pathways.
MATERIALS AND METHODS
PLASMIDS AND ANTIBODIES
Zyxin-shRNA construct (Clone ID: V2MM_26449) targeting rat
zyxin (GenBank accession number: XM_216124; targeting sites:
1622–1640) were purchased from Open Biosystems (Huntsville,
AL). Negative control shRNA pRS plasmid was from Origene
Technologies (Rockville, MD). Antibodies for zyxin, LPP, TRIP6,
and RhoAwere from Santa Cruz Biotechnology (Santa Cruz, CA).
Antibodies for integrin α5, β1, β3, ILK, Rac1, VASP, paxillin, vin-
culin, FAK, and c-Src were purchased from Millipore (Billerica,
MA). ß-actin antibody was from Sigma (St. Louis, MO). Purified
collagen type I, fibrinogen, vitronectin, and laminin were from
BD Biosciences (San Jose, CA) and purified FN was purchased
from Invitrogen (Carlsbad, CA).
CELL CULTURE AND TRANSFECTION
All animals were handled in accordance with the guidelines of the
Animal Care and Use Committee of the University of Missouri
using approved protocols. VSMC were isolated from first-order
feed arterioles of rat cremaster muscles according to the pro-
tocol described by Wu et al. (1998), Cells were cultured in
DMEM/F-12 (Invitorgen; Carlsbad, CA) supplemented with 10%
fetal bovine serum (FBS) and used in the experiments at pas-
sages 3–10. For transfection and selection of stably transfected
clones, cells were transfected using Fugene 6 reagent according to
the protocol described by the manufacturer (Roche; Indianapolis,
IN). The ratio of Fugene 6 reagent to plasmid DNA was main-
tained at 3μl of Fugene 6 reagent to 2μg of plasmid DNA.
Briefly, 94μl of serum-free medium was mixed with 6μl of
Fugene 6 reagent and incubated for 5min at room tempera-
ture, and then 4μg of plasmid DNA was added to the cocktail
and incubated for 45min. This mixture was added drop wise
to cells that have been resuspended in 2ml of fresh regular cul-
ture medium at the density of 105/ml, mixed well and returned
to the incubator. Zyxin-GFP expression can usually be observed
in 48 h. To establish stably transfected VSMC clones, 6 days
after the start of transfection, mixed culture of stably transfected
VSMC clones were obtained by treating the transfected cells with
2.5μg/ml puromycin (Invitrogen, Carlsbad, CA) continuously
for 6–8 weeks.
CELL-ADHESION ASSAY
Adhesion assays were carried out in 96-well plates pretreated
with different substrates. The plates were washed with PBS twice
and then blocked with 0.1% BSA in regular culture medium at
37◦C for 1 h. After cells were trypsinized and resuspended in
serum free DMEM-F12 medium supplemented with 0.1% BSA,
100μl of resuspended cells (2 × 105/ml) was placed to each well
and returned to 37◦C incubator for 1 h. Non-adherent cells were
washed off with PBS twice and attached cells were fixed with 2%
paraformaldehyde at room temperature for 15min. Attached cells
were washed and stained with Crystal Violet (1mg/ml in purified
water) for 10min at room temperature. The plates were allowed
to dry completely and 50μl of 2% SDS was placed to each well
after being washed with water. After incubating at room temper-
ature for 30min, the plates were read at 560 nm on a Bio-Tek
Synergy HT plate reader.
CELL SPREADING ASSAY
Cell spreading assays were performed by plating cells on 50μg/ml
FN-coated dishes for 1, 3, and 5 h under standard culture
conditions. Cells were then fixed and stained with Alexa 568
conjugated-phalloidin. Images were taken with an Olympus con-
focal microscope. Cell areas were determined using NIH Image J
software.
CELL MIGRATION ASSAY
The migration assays were undertaken following protocols
described by Chao et al. (2006). Briefly, A Boyden chamber
with 48 wells and membranes with pores of 8μm (Neuro
Probe, Gaithersburg, MD) were used. The membranes were
pretreated with 50μg/ml FN overnight at 4◦C and blocked
with DMEM/F-12 medium supplemented with 0.1% BSA.
In each well of the lower chamber, 30μl of DMEM/F-12
containing 0.1% BSA and 50μg/ml FN were placed as the
chemoattractants, and in each well of the upper chamber,
50μl of cells (4 × 105/ml) was added. After incubation at
37◦C for 3 h, cells in the upper chamber and non-migrated
cells on the topside of the membrane were removed, and
migrated cells on the lower side of the membrane were
fixed and stained with Diff-Quik stain kit following instruc-
tion by the manufacturer (Fisher Scientific, Pittsburg, PA).
The membranes were then scanned and staining intensity of
migrated cells was determined with a densitometric method
(NIH Image J).
ATOMIC FORCE MICROSCOPY
The method previously described by Sun et al. (2005, 2008) was
used for mechanical force measurement. Briefly, an atomic force
microscope (Bioscope; model IVa; Digital Instruments, Santa
Barbara, CA) mounted on an inverted microscope (Olympus,
IX81, Long Island, NY) was used in contact mode operation.
To measure the VSMC mechano-responsiveness to axial pulling
forces, silicon nitride cantilevers (model MLCT-AUHW; Veeco,
Camarillo, CA) with a spring constant of 0.01N/m were used
(Novascan, Ames, IA). Cantilevers were tipped with a 5-μm
bead coated with PEG-biotin and FN. The beads were incu-
bated with 3mg/ml avitin (Sigma, St. Louis, MO) then washed
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with DPBS and labeled with 1mg/ml FN-biotin conjugates, fol-
lowed by washing with DPBS to remove the unbound FN.
The cantilever tips with FN-coupled beads were put onto the
AFM and brought into contact with the cell surface and main-
tained for 20min, during which period FN on the bead interact
with integrin receptors. Mechanical forces were then applied by
pulling the cantilever tip upward in the axial direction of the
z-axis, and the subsequent bead movement was recorded using
AFM, which reflected the generation of a VSMC mechanical
response to the applied pulling force. Experiments were carried
out in DMEM/F-12 medium at room temperature. Matlab soft-
ware (Math-Works, Natick, MA) was used to analyze the VSMC
mechanical response to forces. To further quantify and compare
the cellular mechanical responses, data were analyzed and the cell
responses expressed as fractional compensation (fc) according to
the formula:
f c = (DAFM − Dcell) /DAFM
DAFM: the initial distance that bead was lifted in the z-axis
following the pull with the AFM cantilever (Figures 1A,B).
Dcell : the ending distance that the bead was from its pre-pulling
position after the cell’s local contractile response (Figures 1A,B).
For the adhesion probability and rupture force measurement,
AFM probes were washed with water and incubated with PEG
(Molecular weight: 8000, 10mg/ml) for 10min at room tem-
perature. After washing with water, the probes were coated with
FN (1mg/ml) for 10min. After washing, the AFM probe was
interacted with the cell surface in a cyclic fashion to approach,
contact and then retract from the cell membrane in force mode
operation. During AFM probe retraction, if a specific binding
event occurred, the rupture of this binding (failure force) was
detected as a small sharp shift in the retraction curve reflect-
ing an abrupt change in cantilever deflection. The rupture forces
of integrin-ECM interactions were analyzed using NforceR soft-
ware (Trzeciakowski and Meininger, 2005). The sampling order
was assigned randomly. For each of the control and zyxin-shRNA
groups, 1000 force curves were pooled from 20 randomly selected
cells (50 curves per cell) with each probe. The adhesion prob-
abilities were determined as the number of force curves with
binding events divided by the number of total force curves
pooled.
CONFOCAL LASER SCANNING MICROSCOPY
Cells at 50–70% confluency were trypsinized and plated on
35mm culture dishes (FluoroDish, World Precision Instruments;
Sarasota, FL). Cells were incubated with primary antibodies
(1:200 dilution-μg/ml) in antibody buffer (15mM Na3C6H5O7,
150mM NaCl, 2% BSA, and 0.05% Triton X-100) at 4◦C
overnight after being fixed with 2% paraformaldehyde and
washed with 0.1mM glycine buffer. Cells were incubated with
Alexa 488-conjugated secondary antibody (goat anti-rabbit, goat
anti-mouse, or rabbit anti-goat IgG) (1:100 dilution-μg/ml)
and/or Alexa 568-conjugated phalloidin (1:100-μg/ml dilution)
in a dark environment for 1 h after being washed with cold
buffer (15mM Na3C6H5O7, 150mM NaCl, and 0.05% Triton
X-100). After cells were washed with cold buffer, images of the
cells were taken on a confocal microscope (Olympus FV 1000)
using excitation wavelengths of 488 nm and 561 nm, respec-
tively. Image analysis was performed using the Olympus FV 1000
software.
WESTERN BLOT ANALYSIS
After being washed twice with ice-cold PBS, cells were lysed in
CSK buffer (50mM NaCl, 300mM sucrose, 3mM MgCl2, and
10mM PIPES at pH6.8) supplemented with 1μg/ml pepstatin
and a complete protease inhibitor cocktail (Roche, Indianapolis,
IN). The BCA Protein Assay Kit (PIERCE; Rockford, IL) was
used to measure protein concentrations. Equal amounts of
total proteins were loaded on SDS-PAGE gels and transferred
to PVDF membranes using the NuPAGE electrophoresis sys-
tem from Invitrogen (Carlsbad, CA). After being incubated in
blocking buffer (TBS containing 2% milk and 0.1% Tween 20)
for 30min at room temperature, the membrane was incubated
in blocking buffer with primary antibodies at 4◦C overnight.
After being washed with TBS containing 0.1% Tween 20 for 6
times, the membrane was visualized using the Visualizer Western
Blot Detection Kit (Millipore, Billerica, MA). For loading con-
trol, the membranes were stripped using Stripping Buffer II
(Upstate; Lake Placid, New York) and incubated with anti-ß-
actin antibody. The protein bands on the films were quantified
using DNR’s GelQuant software (DNR Bio-Imaging Systems
Ltd, Jerusalem, Israel) and normalized to the corresponding
ß-actin band.
FIGURE 1 | (A) A schematic illustration of AFM pulling experiment on
VSMC cell: a, AFM cantilever probe with a FN-coated bead at the tip
forms focal adhesion on VSMC surface; b, AFM pulling force (800 pN)
was applied to FN-focal adhesion by altering the cantilever deflection,
and lifted the FN-bead and focal adhesion; c, while AFM pulling force
was maintained constant, VSMC developed contraction and pulled the
FN-bead and focal adhesion downward. (B) AFM recording of the bead
displacement during the pulling experiment shown in (A). DAFM and
Dcell were measured as shown and were used to calculate the cell
compensation.
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STATISTICAL ANALYSIS
Experimental data are presented as means ± SEM. Each
experiment was repeated at least three times and representative
results are shown. Statistical analyses were performed using stu-
dent t-test on Microsoft Excel and ANOVA analysis of SAS9.1.
P < 0.05 was considered statistically significant.
RESULTS
FORCE-INDUCED RECRUITMENT OF ZYXIN-GFP TO FN FOCAL
ADHESION SITES
To visualize the participation of zyxin in the VSMC mechan-
otransduction, VSMCs were transiently transfected with a zyxin-
GFP construct. A FN-coated microsphere immobilized at the tip
of an AFM probe was applied to cell surface to induce focal
adhesion, and to mediate the AFM pulling forces. As shown
in Figures 2A,B, AFM pulling force significantly augmented the
accumulation of zyxin-GFP to the FN-adhesion site indicating
that the zyxin translocation was force sensitive in VSMC. Since
zyxin has been shown to regulate actin polymerization at focal
adhesions, the changes of actin reorganization after the applica-
tion of pulling force were also tested using similar approach and
an actin-mRFP construct. As shown in Figures 2C,D, the actin
reorganization also occurred at the pulling site in minutes after
the force was applied through FN-coated bead, a time scale very
similar to that of zyxin.
SUPPRESSION OF ZYXIN EXPRESSION BY shRNA SILENCING
To reduce zyxin expression levels in VSMC, cells were trans-
fected with a zyxin-shRNA construct and stably expressed clones
were obtained by treating the transfected cells with 2.5μg/ml
puromycin continuously. A separate group of cells stably express-
ing a negative non-silenced construct were used as control. As
shown by immunofluorescent labeling probed with an anti-zyxin
antibody, zyxin expression level was significantly reduced in
VSMC stably expressing zyxin-shRNA construct in comparison
with control cells (Figure 3A). Western blot analysis confirmed
that there was a significant reduction in zyxin protein expres-
sion level (26 ± 3% of control) in zyxin-shRNA silenced cells
compared to non-silenced control cells (Figure 3B).
ZYXIN shRNA SILENCING AFFECTED VSMC MECHANICAL RESPONSE
TO PULLING FORCES
Similar to previous studies (Sun et al., 2008) from our group
VSMCs developed contractile responses to a pulling force
(800 pN) applied with the AFM to a single FN-integrin adhe-
sion (Figure 4A). After zyxin silencing the VSMC’s response
FIGURE 2 | (A) Accumulation of zyxin-GFP around a FN-coated microsphere
(10μm) applied on the VSMC surface using AFM. FN-bead AFM probes were
engaged to cell surface for 65min before pulling forces were applied
stepwise (2000 pN/step). The white circle illustrate the position of FN-bead,
and white arrow pointing to the zyxin clustering. (B) The time course of
zyxin-GFP recruitment to the FN-bead adhesion site quantified as normalized
fluorescence intensity. (C) Accumulation of actin-RFP around a FN-coated
microsphere (10μm) applied on the VSMC surface using AFM. The white
circle illustrate the position of FN-bead. (D) The time course of actin-RFP
recruitment to the FN-bead adhesion site quantified as normalized
fluorescence intensity. A z-stack of through-focus confocal fluorescence
images were captured through the whole cell depth at each time point.
Images containing signals corresponding to the surface of FN-bead were
stacked together, quantified and normalized to the sum of zyxin
(actin)-recruitment at t = 65 (60min). N = 5 experiments, respectively; data
presented as mean ± SEM. *p < 0.05 compared to zyxin accumulation at
t = 65min; #p < 0.05 compared to acin accumulation at t = 60min. Scale bar
= 10μm.
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FIGURE 3 | Immunofluorescence (A) and Western blots (B) probed with
anti-zyxin antibody showed that zyxin expression was reduced in VSMC
stably expressing zyxin-shRNA construct in comparison with cells
expressing non-silencing control. Images were taken with a 60x oil
objective. Scale bars, 30μm. Blots were quantified and normalized to β-actin
and displayed as percent of control. Control and Zyxin-silenced samples were
run on the same immunoblot and were from the same film exposure. The
results are representative of three independent experiments.
to mechanical pulling force was significantly diminished
(Figure 4A). As shown in Figure 4B, the zyxin-silenced VSMC
failed to generate a positive compensatory mechanical response
(−60% vs. 22.5% for control). There was no significant differ-
ence in the tensile elasticity (Figure 4C), indicating that zyxin-
silencing did not affect the strength of focal adhesions in VSMC.
ZYXIN sHRNA SILENCING ENHANCED CELL ADHESION
It has been suggested that zyxin may play a role in cell signal-
ing in the control of cell adhesion, focal adhesion assembly, and
actin stress fiber remodeling (Beckerle, 1986; Crawford et al.,
1992; Golsteyn et al., 1997). In order to understand the underly-
ing mechanisms of how zyxin silencing was reducing mechano-
responsiveness in VSMC, cell adhesion of Zyxin-silenced cells
were measured using both AFM adhesion assay and whole cell
adhesion assays. Interestingly, Zyxin-shRNA silencing cells dis-
played enhanced binding to FN compared to non-silenced control
cells (n = 20, p < 0.001) as shown in Figures 5A,B. In addition,
there was a left-ward shift in the distribution of unbinding forces
to lower levels that was observed in the Zyxin-shRNA silenc-
ing cells (Figure 5A). There was no significant difference in the
protein expression levels of integrins β1, β3, and α5 between
VSMCs expressing zyxin-shRNA construct and non-silencing
control construct (Figure 5C). Further tests were also performed
using 96-well plate adhesion assays, and the results further con-
firmed that silencing of zyxin by shRNA enhanced cell adhesion
significantly not only on FN (Figure 5D), but also on collagen,
fibrinogen, vitronectin and laminin (Figure 5E).
ZYXIN shRNA SILENCING IMPAIRED VSMC SPREADING AND ACTIN
REMODELING
Zyxin has been shown to translocate to stress fibers, and has
been indicated to interact with VASP and actinin in promot-
ing the actin polymerization (Crawford et al., 1992; Hoffman
et al., 2006). Two experiments were performed to examine
whether reorganization of actin filaments was affected in zyxin-
silenced VSMC. First, the cell spreading process was compared
between zyxin-silenced VSMC and control VSMC. It is known
that the process of cell spreading after the initial adhesion
depends on a continuous actin reorganization process. As shown
FIGURE 4 | Zyxin silencing reduced pulling force response in VSMC.
The AFM probe with FN-coated beads were placed into contact with the
cell surface of VSMC (zyxin-shRNA or control). AFM pulling forces were
then applied to the bead from the cell surface in z-axis. The displacement
(nm) of the bead over 250 s was shown to indicate the VSMC response to
the pulling force. (n = 5, p < 0.004 vs. control). (B) Percentage of cell
compensation as an indicator of quantified cellular micro-myogenic
response. (C) Comparison of the apparent pulling elasticity indicating no
significant change in the FN-focal adhesion strength. Error bars represent
standard error of the mean. *p < 0.05.
in Figures 6A,B, the progress of cell spreading was significantly
slowed in zyxin-silenced VSMC compared to control, suggest-
ing that zyxin silencing weakened the actin filament remodel-
ing in VSMC. A second method to access the actin filament
reorganization is to examine actin filaments polymerization after
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FIGURE 5 | Zyxin silencing enhanced VSMC adhesion. (A) Distribution
of integrin-FN adhesion force (unbinding or rupture forces) measured
using atomic force microscopy adhesion assay. (B) Zyxin-shRNA cells
exhibited an increased binding probability to fibronectin. The binding
probability was calculated as: number of force curves with adhesions/the
total number of force curves recorded. (C) The expression level of a5,
b1, and b3 integrins was not altered by zyxin silencing as compared to
control VSMC. Control and Zyxin-silenced samples were run on the same
immunoblot and were from the same film exposure. (D,E) Zyxin silencing
enhanced VSMC cell adhesion as measured with cell adhesion assay.
VSMC stably transfected with control or zyxin-shRNA construct were
plated with serum free culture medium in 96-well plates coated with (D)
fibronectin at concentrations of 0, 2.5, 5, 10, 25, and 50μg/ml or (E)
with different substrates, and were allowed to adhere for 1 h under
standard culture conditions. COL, collagen 10mg/ml; FN, fibronectin
25mg/ml; FGN, fibrinogen 25mg/ml; VN, vitronectin 10mg/ml; LN,
laminin 10mg/ml. Results represent mean ± SE of five independent
experiments. (∗p < 0.05 vs. control).
treating the cells with jasplakinolide, which is a membrane-
permeable agent that reduces the critical concentration of actin
monomers required for actin polymerization (Bubb et al., 2000).
Non-silenced control cells treated with jasplakinolide exhibited
significantly enhanced actin stress fibers as observed by phalloidin
staining, whereas zyxin-shRNA cells treated with jasplakinolide
for an equal period of time exhibited fewer actin stress fibers
(Figures 6C,D), further suggesting that zyxin silencing attenuated
the actin polymerization.
CHANGES OF OTHER FOCAL ADHESION PROTEINS IN
ZYXIN-SILENCED VSMC
Zyxin possesses a nuclear export sequence at its N-terminal region
and has also been shown to translocate to the nucleus dur-
ing cell stretching (Nix and Beckerle, 1997; Ngu et al., 2010),
suggesting that zyxin may possess functions other than modu-
lating focal adhesions and actin cytoskeleton in cells. Therefore,
besides the absence of zyxin in the focal adhesions, there is pos-
sibility that zyxin-silencing can affect other cellular processes
that may contribute to the impaired VSMC mechano-response
to pulling force. A set of western blot experiments were per-
formed to determine whether there were changes in level of
other focal adhesion proteins in zyxin-silenced VSMC. Among
the proteins tested, there were no changes in the expression lev-
els of vinculin, VSAP, cdc42, Src, RhoA, actinin 1, ILK, and
LPP (Figure 7). However, significant increases of focal adhe-
sion kinase (FAK, 215 ± 42% of control, n = 5, p < 0.05) and
thyroid receptor-interacting protein 6 (TRIP6, 163 ± 15% of
control, n = 4, p < 0.01) expressions were observed in zxyin-
silenced VSMC compared to control. In addition, a significant
decrease of Rac1 expression (67± 3% of control, n = 3, p < 0.01)
was also evident (Figure 8A). Immunofluorescence labeling also
demonstrated there were no changes in the presence of paxillin,
vinculin in focal adhesions, while a significantly stronger presence
of TRIP6 at focal adhesions was observed in zyxin-silenced VSMC
(Figure 8B).
DISCUSSION
Zyxin is a phosphoprotein that has been implicated in mod-
ulation of multiple cellular functions, including cell growth,
cell motility, cell adhesion, stress fiber formation, and tumor
growth (Golsteyn et al., 1997; Hoffman et al., 2006; Sy et al.,
2006). We showed here that AFM pulling force-induced accu-
mulation of zyxin to FN-focal adhesions in VSMC, whereas
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FIGURE 6 | Zyxin silencing inhibited VSMC actin cytoskeleton
reorganization. (A) silencing of zyxin inhibited VSMC spreading.
Non-silencing control or zyxin-shRNA transfected VSMCs were
suspended with serum-free culture medium and plated on 50μg/ml
fibronectin-coated dishes for 1, 3, and 5h under standard culture
conditions. Cells were then fixed and stained with Alexa 568
conjugated-Phalloidin. Images were taken with a 40x oil objective. Scale
Bars, 30μm. (B) Bar graphs represent mean of cell spreading areas
calculated using NIH Image J (*p < 0.05 vs. control). Error bars
represent error of the mean. Results are representative of five
independent experiments. (C) Silencing of zyxin inhibited
jasplakinolide-induced actin-filament strengthening. (D) Bar graphs
represent mean of actin-staining fluorescence intensity of individual cells.
CK4-DMSO, n = 15; CK4-JSP, n = 13; zyxin-DMSO, n = 13; and zyxin-JSP,
n = 13. VSMCs stably transfected with non-silenced control or
zyxin-shRNA were plated with regular culture medium on 50μg/ml
fibronectin-coated dishes overnight and cells were treated with 100nM
Jasplakinolide for 1 h under standard culture conditions. Cells were then
fixed and stained with phalloidin. The fluorescence intensity of individual
cells was calculated as the sum of a z-stack trans-focus images that
were captured using confocal microscopy. Scale bars, 20μm. (*p < 0.05
vs. control). Results are representative of three independent experiments.
FIGURE 7 | Western blot results showing that zyxin silencing did not
significantly affect the expression of a number of focal adhesion
proteins: Vinculin, VASP, Actinin 1,Cdc42, c-Src, RhoA, ILK, and LPP,
as compared between cells stably expressing zyxin-shRNA and cells
expressing non-silencing control. Control and Zyxin-silenced samples
were run on the same immunoblot and were from the same film
exposure. The results are representative of three independent
experiments.
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FIGURE 8 | Zyxin silencing increased FAK and TRIP6 expression, but
decreased Rac1 expression in VSMC. (A) Western blots showed that
FAK and TRIP6 expression were increased, but Rac1 was decreased in
cells stably expressing zyxin-shRNA compared to cells expressing
non-silencing control. Blots were quantified and normalized to β-actin and
presented as percentage of the control. (B) Immunofluorescence
microscopy showed increased presence of TRIP6 in the focal adhesions
of VSMCs expressing zyxin-shRNA, but no significant change was
observed in the focal adhesion presence of paxillin and vinculin. Control
and Zyxin-silenced samples were run on the same immunoblot and were
from the same film exposure. The results are representative of three
independent experiments. Scale bars, 30μm.
knock-down of zyxin expression by transfecting VSMC with a
zyxin-shRNA construct abolished cell contraction in response
to AFM pulling force applied through FN-focal adhesions. This
evidence supports zyxin involvement in the integrin-mediated
mechanotransduction in VSMC. Further experiments revealed
that RNAi-silencing of zyxin did not alter integrin expression
but significantly enhanced cell adhesion with ECM proteins (FN,
CN type I, Laminin, vitronectin, and fibrinogen). Reducing zyxin
expression also slowed cell spreading and the process of actin
reorganization in VSMC. The latter effect could explain the abol-
ishment of VSMC mechano-response. In addition, there was
also a significant increase of TRIP6 and FAK expression, but a
decrease of Rac expression in zyxin-silenced VSMC compared
to control. These results provide new insights into the multi-
functional role of zyxin in modulating the VSMCmechanotrans-
duction.
Mammalian cell focal adhesions have been an area of focused
research for the past two decades. Much of this work has aimed at
understanding the mechanism of cellular mechano-transduction
(Naruse et al., 1998; Chen et al., 1999; Bershadsky et al., 2003;
Helmke et al., 2003), and also raised interests that focal adhe-
sions could serve as a mechanosensor in VSMC both in vivo
and in vitro (Intengan and Schiffrin, 2000; Schwartz et al., 2003).
Zyxin belongs to a small group of focal adhesionmolecules, which
display translocation when cells were exposed to mechanical
force. Zyxin has been shown to translocate from focal adhesions
to stress fibers and the nucleus in cyclically stretched fibrob-
lasts and endothelial cells (Yoshigi et al., 2005; Ngu et al., 2010).
Furthermore, release of cytoskeletal stress in fibroblast caused
zyxin to dissipate from focal adhesions into the cytosol (Rottner
et al., 2001; Hirata et al., 2008a), while application of external
forces recruited zyxin from cytosol into focal adhesions (Hirata
et al., 2008a). Collectively, evidence points to zyxin as a pro-
tein involved in cellular processes that are mechano-sensitive. In
this report, our results confirmed that zyxin was recruited to FN
focal adhesions that were subjected to locally applied mechanical
forces. Interestingly, the recruitment of actin cytoskeleton under-
neath the FN-adhesion site was also enhanced by pulling forces
following a similar time scale (Figure 2). These observations sup-
port a role for zyxin in modulating cytoskeletal and signaling
behavior during mechanotransduction in VSMC.
The N-terminal proline-rich domain of zyxin has been shown
to form complexes with Mena/VASP family proteins in facilitat-
ing actin-polymerization at focal adhesions and stress fibers in
fibroblast (Yoshigi et al., 2005; Hoffman et al., 2006). Consistent
with these observations, our data demonstrated that zyxin silenc-
ing impaired the processes of actin polymerization and reor-
ganization in VSMC (Figure 4). Previous studies have shown
that actin polymerization is critically involved in the local-
ized VSMC contractile response to FN-mediated mechanical
forces. For example, the VSMC contractile mechano-response
to pull at an FN focal adhesion was totally abolished by
Cytochalasin-D, but was enhanced in the presence of jasplaki-
nolide (Sun et al., 2008). Therefore, we considered that the
impaired actin-polymerization in zyxin-silenced VSMC pro-
vided a possible explanation of the abolished force-induced
contractile response. Interestingly, in Zyxin-silenced VSMC, we
also observed a significant down-regulation of Rac1 expression
(Figure 6A). Rac1 is member of small GTPase family protein,
and is central to the regulation of actin-polymerization that
drives the lamellipodia in fibroblast and VSMC (Lamarche et al.,
1996; Pelletier et al., 2005). It is plausible that down-regulation
of Rac could also contribute to the down-regulation of actin-
polymerization at the FN-adhesion site. Collectively, these data
suggested that zyxin could be an important modulator pro-
moting the actin-polymerization in VSMC by directly com-
plexing with Mena/VASP, while a possible correlation between
zyxin and Rac1 expression is worth further investigation.
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Hoffman et al. has shown that the zyxin-null fibroblasts exhib-
ited augmentation in cell adhesion and motility (Hoffman et al.,
2006). In agreement with these data, in the zyxin-silenced VSMC,
we also observed enhanced cell adhesion (Figure 3) and migra-
tion (data not shown). The enhanced VSMC adhesion was not
accompanied by an increase of integrins that typically bind FN
(Figure 5C), but could be associated with the increased expres-
sion level of FAK (Figure 6A). The increase of FAK expression has
been observed in a broad range of carcinomas, and was generally
associated with increased integrin-ECM adhesion and cell motil-
ity (Gabarra-Niecko et al., 2003). It is plausible that the increase
of VSMC adhesion is mediated by the increased FAK activity.
Unlike FAK, there was no evidence in the literature suggesting
that zyxin or the up-regulated TRIP6 are directly involved in the
regulation of integrin adhesion. TRIP6, another member of the
zyxin family LIM domain proteins, (Yi and Beckerle, 1998; Lin
and Lin, 2011) can also be targeted to focal adhesions. TRIP6
binding partners include supervillin and lysophosphatidic acid
(LPA) 2 receptor (Xu et al., 2004; Takizawa et al., 2006), and
has been suggested to facilitate focal adhesion turnover in epithe-
lial cells and to mediate LPA-induced cell migration (Xu et al.,
2004; Takizawa et al., 2006). Similar to zyxin, RNAi mediated
knock-down of TRIP6-induced increased cell adhesion to FN in
a fibroblast-like cell line COS7 (Takizawa et al., 2006), impli-
cating that TRIP6 may not contribute to the increased VSMC
adhesion.
In addition to enhanced cell-ECM adhesion in zyxin-silenced
VSMC, we also observed a left shift of the integrin-FN adhesion
force using AFM adhesion analysis, suggesting a possibility that
zyxin, FAK or TRIP6 could be regulating the binding activity of
integrin with ECM proteins. This observation is consistent with
data reported by Ngu et al. that silencing of zyxin enhanced cell
adhesion but reduced the initial adhesion strength in endothelial
cells (Ngu et al., 2010). It is interesting that the improved VSMC
adhesion, by itself, did not enhance the mechano-responsiveness
of the VSMC. The reason for this is not clear. It may suggest that
the ability to develop a contractile response depends more on
unique compositional and structural characteristics of the focal
adhesion complex underlying the adhesion site. As an example,
the down-regulation of zyxin and Rac1 seem to be sufficient to
prevent development of a mechanically responsive focal adhesion
site with FN.
Zyxin possesses an N-terminal nuclear transport signal and
has been postulated to shuttle between focal adhesion sites and
the cell nucleus as a way of mediating protein expression changes
that accompany cellular mechanotransduction (Nix and Beckerle,
1997; Hervy et al., 2006). In this regard, Cattaruzza et al. have
reported that silencing of Zyxin alteredmechanical stress-induced
gene expression in VSMC (Cattaruzza et al., 2004). In this
study, altered expression of FAK, TRIP6, and Rac were observed
in zyxin-silenced VSMC compared to control. Interestingly, a
decreased expression of zyxin has been reported in laryngeal squa-
mous cell carcinoma (Wu et al., 2011), while an increase of FAK
expression has also been reported in the head and neck squamous
cell carcinomas (Agochiya et al., 1999), supporting a possible
correlation between FAK and zyxin expression levels. It should
be noted that, while changes of these protein levels were found
in zyxin-silenced cells, how the gene expression of FAK, TRIP6,
and Rac1 was regulated and whether zyxin is directly involved in
the regulation of these proteins is not clear. Future investigation
will be needed to determine the possible interactions/crosstalks
between zyxin and FAK, TRIP6 and Rac1.
In summary, the results reported here demonstrate that zyxin
plays an important role in mechanotransduction of microvascu-
lar VSMC and the ability of VSMC to respond to mechanical
force with a contractile change. A relationship between zyxin and
functions involving the actin cytoskeleton likely enable it’s role in
modulating mechanosensitivity focal adhesion sites in VSMC.
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